A high interferon gamma signature of CD8 + T cells predicts response to neoadjuvant immunotherapy plus chemotherapy in gastric cancer.
Frontiers in immunology(2022)
Abstract
Our data reveal interactions between the TME and neoadjuvant immunotherapy plus chemotherapy in GC. Importantly, it also highlights the signature of CD8 T cells in predicting response to the combination therapy in GC.
MoreTranslated text
Key words
gastric cancer,immune checkpoint blockade,interferon gamma,neoadjuvant immunotherapy,single-cell RNA sequencing,tumor microenvironment
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined